Cardio-Oncology & Cardiotoxicity

Cardio-oncology focuses on the cardiovascular complications arising from cancer therapies, including chemotherapy, radiotherapy, and targeted treatments. Cardiotoxicity, such as heart failure, arrhythmias, and vascular dysfunction, poses significant risks to cancer survivors, necessitating early detection and intervention. Biomarkers, imaging, and precision medicine play a crucial role in mitigating these adverse effects while ensuring effective cancer treatment. Integrating cardiology and oncology care is essential for balancing cancer therapy efficacy with long-term heart health.

 

    Related Conference of Cardio-Oncology & Cardiotoxicity

    October 20-21, 2026

    15th World Heart Congress

    London, UK
    November 09-10, 2026

    7th Annual Summit on Cardiology and Heart Diseases

    Paris, France
    November 16-17, 2026

    8th World Heart Congress

    Tokyo, Japan
    November 23-24, 2026

    40th World Congress on Heart Diseases

    Toronto, Canada
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France
    January 26-27, 2027

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2027

    16th World Heart Congress

    Paris, France
    April 27-28, 2027

    5th International Conference on World Heart Care

    Paris, France
    May 12-13, 2027

    42nd World Cardiology Conference

    London, UK
    May 13-14, 2027

    10th Annual Heart Rhythm Conference

    Rome, Italy
    June 17-18, 2027

    10th World Heart and Brain Conference

    London, UK
    June 21-22, 2027

    8th European Summit on Cardiology Research

    Zurich, Switzerland

    Cardio-Oncology & Cardiotoxicity Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in